Mood disorders are treated with a combination of medication, therapy, and lifestyle changes, tailored to whether the condition involves depression, bipolar disorder, or a related diagnosis. The specific approach depends on the type and severity of symptoms, but most people see meaningful improvement with the right treatment plan. Here’s what that looks like in practice.
Types of Mood Disorders Shape Treatment
The term “mood disorder” covers two main categories: depressive disorders and bipolar disorders. Major depressive disorder involves persistent low mood, loss of interest, and changes in sleep, appetite, or energy. Bipolar disorder comes in two forms: bipolar I, which involves full manic episodes (periods of extremely elevated mood, energy, and impulsive behavior), and bipolar II, which involves less intense hypomanic episodes paired with depressive periods. Cyclothymic disorder is a milder but chronic pattern of mood swings that don’t reach the full intensity of bipolar episodes.
This distinction matters because treatments that help depression can sometimes worsen bipolar disorder. An antidepressant given without a mood stabilizer to someone with bipolar disorder can trigger a manic episode. Getting the right diagnosis is the first and most important step.
Medication for Depression
For major depressive disorder, the most commonly prescribed medications work by increasing the availability of chemical messengers in the brain that regulate mood. The two first-line classes are SSRIs and SNRIs. SSRIs boost serotonin levels, while SNRIs boost both serotonin and norepinephrine. Both are considered first-line treatments because they work reasonably well and cause fewer serious side effects than older options.
That said, side effects are still common. In clinical comparisons, about 32% of people on SSRIs and 37% on SNRIs reported mild to moderate side effects, which often include nausea, weight changes, sleep disruption, or sexual difficulties. Newer medications targeting different brain pathways show lower side effect rates (around 25%) and better adherence, though they aren’t yet as widely prescribed.
Most antidepressants take two to six weeks to reach full effect. If the first medication doesn’t help enough, switching to a different one or adding a second medication is standard. This trial-and-adjustment period can be frustrating, but it’s a normal part of finding the right fit.
Medication for Bipolar Disorder
Bipolar disorder requires mood stabilizers, which prevent the extreme highs and lows rather than simply lifting mood. Lithium remains one of the most effective options, particularly for preventing manic episodes and reducing suicide risk. Starting lithium requires some medical groundwork: kidney function, thyroid levels, and heart rhythm all need to be checked first. Lithium levels in the blood must be monitored regularly because the effective dose is close to the level that causes side effects. Dehydration, salt-restricted diets, and certain common medications (including ibuprofen and similar anti-inflammatory drugs) can push lithium levels dangerously high.
Valproate is another widely used mood stabilizer, particularly for acute manic episodes. Blood levels are monitored similarly to lithium, typically checked about five days after starting or adjusting the dose. Lamotrigine plays a different role: it’s especially useful for preventing bipolar depressive episodes rather than mania, and it has a more favorable safety profile during pregnancy compared to other mood stabilizers.
Atypical antipsychotics are also frequently used in bipolar disorder, either alone or alongside a mood stabilizer, particularly during acute manic or mixed episodes.
Therapy That Works for Mood Disorders
Medication handles the biological side, but therapy addresses the thought patterns, behaviors, and relationship problems that fuel mood episodes. Two approaches have the strongest evidence for depression: cognitive behavioral therapy (CBT) and interpersonal therapy (IPT).
CBT focuses on the idea that your emotional reactions are shaped not by events themselves but by how you interpret them. A person prone to depression might automatically assume the worst in ambiguous situations, and CBT teaches skills to recognize and challenge those patterns. IPT takes a different angle, focusing on improving relationships and social functioning, which are both disrupted by and contributors to depression. Both are time-limited, typically running 12 to 20 sessions.
In head-to-head comparisons, CBT and IPT perform similarly well. One controlled study found that 76% of people in CBT and 79% in IPT showed clinically meaningful improvement in depressive symptoms. The best choice often comes down to what resonates with you: if your depression is tangled up in relationship conflict or grief, IPT may feel more relevant. If you’re stuck in cycles of negative thinking, CBT may click faster.
Dialectical behavior therapy (DBT) is a specialized form originally developed for intense emotional instability. It combines CBT techniques with mindfulness and distress tolerance skills, and it’s particularly useful for people whose mood disorder comes with self-harm, impulsivity, or difficulty managing emotional extremes.
Brain Stimulation for Treatment-Resistant Cases
When medication and therapy aren’t enough, brain stimulation therapies offer another path. Electroconvulsive therapy (ECT) is the most effective option for severe, treatment-resistant depression. It involves brief electrical stimulation of the brain under general anesthesia and is typically given two to three times per week for several weeks. ECT achieves a response rate of about 64% and full remission in roughly 53% of patients who haven’t responded to other treatments.
Transcranial magnetic stimulation (TMS) is a less invasive alternative. It uses magnetic pulses directed at the left front of the brain and doesn’t require anesthesia. You sit in a chair during sessions that last about 20 to 40 minutes. High-frequency TMS produces response rates around 49% and remission in about 32% of treatment-resistant patients. That’s lower than ECT, but TMS avoids the memory side effects and anesthesia risks that come with ECT, making it a reasonable first step before considering more intensive options.
Rapid-Acting Options for Severe Depression
One of the biggest frustrations with traditional antidepressants is the weeks-long wait for them to work. Esketamine, a nasal spray derived from the anesthetic ketamine, can produce noticeable mood improvement within hours to days. It’s approved specifically for treatment-resistant depression and for depressive episodes with suicidal thoughts.
The catch is that esketamine can’t be picked up at a pharmacy and used at home. It must be administered in a certified healthcare setting. You spray it yourself, but under direct observation, and you’re monitored for at least two hours afterward because of the risk of sedation and dissociation (a feeling of being detached from your body or surroundings). You can’t drive for the rest of the day after a session. Treatment typically starts at twice weekly, then tapers to weekly or every other week.
Exercise as a Treatment Tool
Physical activity has a measurable antidepressant effect, and the threshold is lower than most people expect. Running for just 15 minutes a day, or walking for an hour, reduces the risk of major depression. These aren’t vague wellness suggestions: the effect sizes in research are comparable to what you’d see from some medications, particularly for mild to moderate depression.
Higher-intensity exercise works in shorter bursts, while lower-intensity activity like walking, gardening, or housework needs more time to produce the same benefit. For people already on medication, regular exercise tends to amplify the effect. It also improves sleep, reduces anxiety, and counteracts some medication-related weight gain, making it one of the highest-value additions to any treatment plan.
Treatment During Pregnancy
Managing mood disorders during pregnancy requires careful risk balancing. Untreated severe bipolar disorder or depression carries real dangers, including self-harm and complications from poor self-care. But several mood stabilizers carry known risks to the developing baby, particularly during the first trimester.
Lithium exposure in the first trimester is linked to a rare heart defect called Ebstein’s anomaly, though the actual risk is lower than initially feared: roughly 1 in 1,000 to 1 in 2,000 births. Lithium use during the second and third trimesters appears safer. Valproate is more concerning, as first-trimester exposure is associated with major malformations, developmental delays, lower IQ, and higher rates of autism spectrum disorder. Carbamazepine carries similar risks and is generally avoided in early pregnancy.
Lamotrigine has the most favorable safety data among mood stabilizers during pregnancy. Atypical antipsychotics are also considered a reasonable option for pregnant women with bipolar disorder. For women with severe illness, stopping medication entirely during pregnancy can be riskier than continuing a carefully chosen drug at the lowest effective dose, but this is always an individualized decision.
Watching for Serotonin Syndrome
Anyone taking medications that boost serotonin should know about serotonin syndrome, a potentially dangerous reaction that occurs when serotonin levels climb too high. This most often happens when a new serotonin-boosting medication is started, a dose is increased, or two serotonergic drugs overlap. Some non-psychiatric medications can also contribute by slowing the breakdown of antidepressants in the body, including certain antibiotics and antifungals.
Symptoms include involuntary muscle twitching or jerking, agitation, heavy sweating, rapid heartbeat, and overactive reflexes. In severe cases, body temperature rises above 100.4°F and muscles become rigid. The most dangerous cases tend to involve older antidepressants called MAOIs, but any combination of serotonin-boosting drugs can cause it. If you’re stable on a single medication at a consistent dose, spontaneous serotonin syndrome is unlikely. The risk comes from changes: new drugs, dose adjustments, or accidental interactions.